Apogee Therapeutics, Inc.
APGEDelisted Sep 3, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001974640
Apogee Therapeutics, Inc. was delisted on Sep 3, 2026; its insiders filed their last Form 4 on Sep 3, 2026; 288 institutions reported holding it in 13F filings for Q2 2026, worth $8.93B in total; Soros Fund Management was the only superinvestor holding it.
Q4 2023 vs. Q3 2023
How the institutions holding Apogee Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 73 | 85 | +12 |
| Shares | 40.1M | 41.8M | +1.66M (+4.1%) |
| Value | $848.7M | $1.16B | +$315.0M (+37.1%) |
New holders (21)
Institutions that held Apogee Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jennison Associates LLC | 103,744 | $2.90M | 0.00% |
| Barclays PLC | 34,056 | $951.5K | 0.00% |
| Swiss National Bank | 33,000 | $922.0K | 0.00% |
| Millennium Management LLC | 28,775 | $804.0K | 0.00% |
| Two Sigma Investments, LP | 25,039 | $699.6K | 0.00% |
| Hudson Bay Capital Management LP | 20,000 | $558.8K | 0.00% |
| Jump Financial, LLC | 18,344 | $512.5K | 0.02% |
| Credit Suisse AG | 14,737 | $411.8K | 0.00% |
| State of Wisconsin Investment Board | 13,786 | $385.2K | 0.00% |
| Alliancebernstein L.P. | 10,640 | $297.3K | 0.00% |
| Artia Global Partners LP | 10,381 | $290.0K | 0.11% |
| Susquehanna International Group, LLP | 9,481 | $264.9K | 0.00% |
| Norges Bank | 9,231 | $257.9K | 0.00% |
| Voya Investment Management LLC | 8,153 | $227.8K | 0.00% |
| China Universal Asset Management Co., Ltd. | 5,555 | $155.2K | 0.03% |
| Virtus ETF Advisers LLC | 3,984 | $111.3K | 0.07% |
| Citigroup Inc | 3,769 | $105.3K | 0.00% |
| EntryPoint Capital, LLC | 1,380 | $38.6K | 0.04% |
| Daiwa Securities Group Inc. | 196 | $5.00K | 0.00% |
| Red Tortoise LLC | 94 | $2.63K | 0.00% |
| Glassman Wealth Services | 12 | $335 | 0.00% |
Sold out (9)
Institutions that held Apogee Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Citadel Advisors LLC | 243,126 | $5.18M |
| Seven Grand Managers, LLC | 48,198 | $1.03M |
| Tudor Investment Corp Et Al | 12,515 | $266.6K |
| Bayesian Capital Management, LP | 11,142 | $237.3K |
| Davidson Kempner Capital Management LP | 10,000 | $212.7K |
| Meeder Asset Management Inc | 6,632 | $141.3K |
| UBS Group AG | 3,557 | $75.8K |
| CWM, LLC | 181 | $4.00K |
| The PNC Financial Services Group, Inc. | 48 | $1.02K |